Terms: = Breast cancer AND FANCA, MGC75158, 2175, ENSG00000187741, FA-H, FA, FAA, FANCH, FA1, FACA AND Treatment
283 results:
1. Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer.
Montaseri H; Abrahamse H
Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):270-277. PubMed ID: 38696132
[TBL] [Abstract] [Full Text] [Related]
2. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
3. Application of fluorocarbon nanoparticles of
Zhi L; Cheng C; Jing L; Zhi-Ping P; Lu Y; Yan T; Zhi-Gang W; Guo-Bing Y
J Nanobiotechnology; 2024 Mar; 22(1):107. PubMed ID: 38475902
[TBL] [Abstract] [Full Text] [Related]
4. treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
[TBL] [Abstract] [Full Text] [Related]
5. Effect of physical exercise on immune, inflammatory, cardiometabolic biomarkers, and fatty acids of breast cancer survivors: results from the MAMA_MOVE Gaia After treatment trial.
Joaquim A; Góis A; Soares A; Garcia C; Amarelo A; Antunes P; Afreixo V; Geraldes V; Capela A; Viamonte S; Alves AJ; Ferreira HB; Guerra I; Afonso AI; Domingues MR; Helguero LA
Support Care Cancer; 2024 Feb; 32(3):174. PubMed ID: 38378875
[TBL] [Abstract] [Full Text] [Related]
6. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract] [Full Text] [Related]
7. Mucilage-assisted fabrication of molybdenum trioxide nanostructures for photothermal ablation of breast cancer cells.
Alomari RA; Athinarayanan J; Periasamy VS; Alshatwi AA
Biotechnol Appl Biochem; 2024 Apr; 71(2):326-335. PubMed ID: 38112040
[TBL] [Abstract] [Full Text] [Related]
8. Tumour-specific hybrid nanoparticles in therapy of breast cancer.
Kilicay E; Erdal E; Elci P; Hazer B; Denkbas EB
J Microencapsul; 2024 Jan; 41(1):45-65. PubMed ID: 38095892
[TBL] [Abstract] [Full Text] [Related]
9. Polyphenol modified CuO nanorods capped by kappa-carrageenan for controlled paclitaxel release in furnishing targeted chemotherapy in breast carcinoma cells.
Singh S; Pal K
Int J Biol Macromol; 2024 Jan; 255():127893. PubMed ID: 37949284
[TBL] [Abstract] [Full Text] [Related]
10. Association between CD10 expression and phyllodes tumor: A retrospective case control study.
Tian F; Zhao J; Shi QF; Zhang DC; Wang YY; Sun JP; Wang Y; Yang SA; Zhang C
Medicine (Baltimore); 2023 Nov; 102(44):e35677. PubMed ID: 37933030
[TBL] [Abstract] [Full Text] [Related]
11. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade.
Hamed A; Ghareeb D; Mohamed TM; Hamed M; Nofal MS; Gaber M
BMC Complement Med Ther; 2023 Oct; 23(1):384. PubMed ID: 37891562
[TBL] [Abstract] [Full Text] [Related]
12. Diselenium-linked dimeric prodrug nanomedicine breaking the intracellular redox balance for triple-negative breast cancer targeted therapy.
Chen M; Zhang M; Lu X; Li Y; Lu C
Eur J Pharm Biopharm; 2023 Dec; 193():16-27. PubMed ID: 37865134
[TBL] [Abstract] [Full Text] [Related]
13. PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in cancer Cells and Improve Response to PARP Inhibition and Chemotherapies.
Carter J; Hulse M; Sivakumar M; Burtell J; Thodima V; Wang M; Agarwal A; Vykuntam K; Spruance J; Bhagwat N; Rager J; Ruggeri B; Scherle P; Ito K
Cancer Res Commun; 2023 Nov; 3(11):2233-2243. PubMed ID: 37861290
[TBL] [Abstract] [Full Text] [Related]
14. Validation of Dual-Action Chemo-Radio-Labeled Nanocarriers with High Efficacy against Triple-Negative breast cancer.
Ilyas S; E M Sahnoun S; Szymura A; Pes J; Habib S; Florea A; Schäfer L; Buhl EM; Morgenroth A; Habib P; Mottaghy FM; Mathur S
ACS Appl Mater Interfaces; 2023 Oct; 15(42):48963-48977. PubMed ID: 37831583
[TBL] [Abstract] [Full Text] [Related]
15. Actively targeted gold-polydopamine (PDA@Au) nanocomplex for sequential drug release and combined synergistic chemo-photothermal therapeutic effects.
Singh S; Pal K
Int J Pharm; 2023 Oct; 645():123374. PubMed ID: 37673278
[TBL] [Abstract] [Full Text] [Related]
16. Hepatic adenoma in a 7-year-old girl: a case report and literature review.
Gao Y; Zhou J; Xie YC; Qiu LJ; Duan L; A ZX; Wu HF; Lv MX
BMC Pediatr; 2023 Aug; 23(1):420. PubMed ID: 37620840
[TBL] [Abstract] [Full Text] [Related]
17. pH-triggered "PEG" sheddable and folic acid-targeted nanoparticles for docetaxel delivery in breast cancer treatment.
Sui F; Fang Z; Li L; Wan X; Zhang Y; Cai X
Int J Pharm; 2023 Sep; 644():123293. PubMed ID: 37541534
[TBL] [Abstract] [Full Text] [Related]
18. MCL1 Inhibition Overcomes the Aggressiveness Features of Triple-Negative breast cancer MDA-MB-231 Cells.
Pratelli G; Carlisi D; Di Liberto D; Notaro A; Giuliano M; D'Anneo A; Lauricella M; Emanuele S; Calvaruso G; De Blasio A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446326
[TBL] [Abstract] [Full Text] [Related]
19. Mitochondrial Metabolism Drives Low-density Lipoprotein-induced breast cancer Cell Migration.
Nóbrega-Pereira S; Santos F; Oliveira Santos M; Serafim TL; Lopes AP; Coutinho D; Carvalho FS; Domingues RM; Domingues P; Bernardes de Jesus B; Morais VA; Dias S
Cancer Res Commun; 2023 Apr; 3(4):709-724. PubMed ID: 37377750
[TBL] [Abstract] [Full Text] [Related]
20. Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer.
Lee K; Lee J; Choi J; Sim SH; Kim JE; Kim MH; Park YH; Kim JH; Koh SJ; Park KH; Kang MJ; Ahn MS; Lee KE; Kim HJ; Ahn HK; Kim HJ; Park KU; Park IH
Sci Rep; 2023 Jun; 13(1):9928. PubMed ID: 37336919
[TBL] [Abstract] [Full Text] [Related]
[Next]
